SQA
MRNA icon

Simon Quick Advisors’s Moderna MRNA Stock Holding History

Simon Quick Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,820
Closed -$216K – 449
2024
Q2 		$216K Buy
+1,820
New +$230K 0.02% 353
2022
Q2 		– Sell
-59
Closed -$10K – 320
2022
Q1 		$10K Buy
59
+3
+5% +$505 ﹤0.01% 302
2021
Q4 		$14K Sell
56
-34
-38% -$9.94K ﹤0.01% 303
2021
Q3 		$34K Buy
90
+20
+29% +$7.38K 0.01% 289
2021
Q2 		$16K Sell
70
-500
-88% -$89.4K ﹤0.01% 350
2021
Q1 		$74K Sell
570
-1,000
-64% -$145K 0.02% 177
2020
Q4 		$164K Buy
1,570
+70
+5% +$7.08K 0.05% 117
2020
Q3 		$106K Sell
1,500
-1,500
-50% -$105K 0.03% 126
2020
Q2 		$193K Buy
3,000
+1,500
+100% +$82.1K 0.07% 84
2020
Q1 		$45K Buy
+1,500
New +$34.5K 0.02% 195

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Simon Quick Advisors's MRNA Position: Q3 2024 in Review

Simon Quick Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 1,820 shares — an estimated $216K sold.

Simon Quick Advisors first reported a position in MRNA in Q1 2020 and held it in 10 quarters. The position peaked at $216K in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Simon Quick Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Simon Quick Advisors sold 1,820 Moderna shares in Q3 2024, an estimated $216K.
  • Simon Quick Advisors first reported a position in Moderna in Q1 2020 and held it in 10 quarters.
  • Simon Quick Advisors's Moderna position peaked at $216K in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Simon Quick Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.